A detailed history of Cidel Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cidel Asset Management Inc holds 12,689 shares of LLY stock, worth $9.97 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
12,689
Previous 10,022 26.61%
Holding current value
$9.97 Million
Previous $9.07 Million 23.9%
% of portfolio
0.89%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $2.06 Million - $2.56 Million
2,667 Added 26.61%
12,689 $11.2 Million
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $6.8 Million - $8.52 Million
9,378 Added 1456.21%
10,022 $9.07 Million
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $72,840 - $97,450
-123 Reduced 16.04%
644 $501,000
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $402,820 - $474,872
767 New
767 $447,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $746B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cidel Asset Management Inc Portfolio

Follow Cidel Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cidel Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cidel Asset Management Inc with notifications on news.